Zymeworks (ZYME) Change in Acquisitions & Divestments (2022 - 2026)
Zymeworks (ZYME) reported Change in Acquisitions & Divestments of $70.2 million for Q1 2026, up 50.75% on a YoY basis from $46.6 million in Q1 2025, and up 11.54% sequentially from $62.9 million in Q4 2025.
Zymeworks (ZYME) Change in Acquisitions & Divestments (2022 - 2026) Analysis & Trends
Zymeworks (ZYME) has 5 years of Change in Acquisitions & Divestments data on file, last reported at $70.2 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Acquisitions & Divestments rose 50.75% year-over-year to $70.2 million; the trailing twelve-month figure through Mar 2026 stood at $248.7 million (down 20.36% YoY), and the FY2025 full-year result was $225.1 million, down 30.87% from the prior year.
- Change in Acquisitions & Divestments climbed to $70.2 million in Q1 2026, from $62.9 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $125.9 million in Q3 2024 to a low of -$46.2 million in Q4 2022.
- A 5-year average of $64.5 million and a median of $62.3 million in 2023 frame the typical range for Change in Acquisitions & Divestments.
- Across the five-year window, Change in Acquisitions & Divestments surged 234.96% in 2023 and tumbled 71.55% in 2025, its largest moves.
- Tracing ZYME's Change in Acquisitions & Divestments over 5 years: stood at -$46.2 million in 2022, then surged by 234.96% to $62.3 million in 2023, then fell by 23.11% to $47.9 million in 2024, then jumped by 31.29% to $62.9 million in 2025, then increased by 11.54% to $70.2 million in 2026.
- Business Quant data shows ZYME's Change in Acquisitions & Divestments at $70.2 million in Q1 2026, $62.9 million in Q4 2025, and $35.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Zymeworks | 1.73 Bn | 1.36 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 70.18 Mn |
| Mar 31, 2026 | 70.18 Mn |
| Dec 31, 2025 | 62.92 Mn |
| Dec 31, 2025 | 62.92 Mn |
| Sep 30, 2025 | 35.83 Mn |
| Sep 30, 2025 | 35.83 Mn |
| Jun 30, 2025 | 79.78 Mn |
| Jun 30, 2025 | 79.78 Mn |
| Mar 31, 2025 | 46.55 Mn |
| Mar 31, 2025 | 46.55 Mn |
| Dec 31, 2024 | 47.92 Mn |
| Dec 31, 2024 | 47.92 Mn |
| Sep 30, 2024 | 125.95 Mn |
| Sep 30, 2024 | 125.95 Mn |
| Jun 30, 2024 | 91.85 Mn |
| Jun 30, 2024 | 91.85 Mn |
| Mar 31, 2024 | 59.85 Mn |
| Mar 31, 2024 | 59.85 Mn |
| Dec 31, 2023 | 62.33 Mn |
| Dec 31, 2023 | 62.33 Mn |